
Tazest 4.5 Injection
Marketer
Viribus Healthcare
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazest 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on illness severity, and must adhere to their prescribed regimen. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, renal or hepatic impairments; dosage adjustments or alternative therapies may be necessary. While generally safe under medical guidance, its use during pregnancy or breastfeeding requires physician oversight.
Uses of Tazest 4.5 Injection
Infections caused by bacteria
Major Benefits of Tazest 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazest 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazest 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazest 4.5 Injection works:
Tazest 4.5 Injection unites Piperacillin, a bacteria-fighting antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum's role is to counteract bacterial resistance mechanisms, thereby optimizing Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Tazest 4.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The administration of Tazest 4.5 Injection during pregnancy is typically deemed safe. Preclinical trials using animal models have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Tazest 4.5 Injection. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Tazest 4.5 Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administration of Tazest 4.5 Injection requires careful monitoring. Dosage modification of Tazest 4.5 Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazest 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Tazest 4.5 Injection :
Omit a Tazest 4.5 Injection dose? Seek your physician's advice.
Facts to Know About Tazest 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
